Navigating the Complex, Uncertain Regulatory Environment to Expedite Global Patient Access to Liquid Biopsy Testing

• How to drive global approvals – and expedited approvals – for liquid biopsies
• Understanding evolving global regulatory landscape and call for harmonization
• Emphasizing the importance of early regulatory considerations in clinical studies

Speakers:

Michelle Neff

Associate Vice President - Global Regulatory Affairs, Diagnostics & Companion Diagnostics

Eli Lilly